Korro Bio Inc.

NASDAQ: KRRO · Real-Time Price · USD
20.27
0.39 (1.96%)
At close: Aug 15, 2025, 3:59 PM
20.66
1.90%
After-hours: Aug 15, 2025, 07:58 PM EDT

Korro Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-83.58M -81.17M -58.03M -21.96M
Depreciation & Amortization
3.56M 3.63M 2.51M 1.59M
Stock-Based Compensation
4.46M 2.38M 1.14M 807K
Other Working Capital
16.63M 1.18M -2.39M 848K
Other Non-Cash Items
1.89M 3.61M 1.51M -13.47M
Deferred Income Tax
n/a -15K -145K 28K
Change in Working Capital
13.59M 4.28M -633K 904K
Operating Cash Flow
-60.07M -67.28M -53.65M -32.09M
Capital Expenditures
-17.9M -7.84M -5.21M -4.45M
Cash Acquisitions
n/a n/a n/a -29.23M
Purchase of Investments
-146.34M n/a -37.21M -35.07M
Sales Maturities Of Investments
40.9M 19M 53.48M 29.23M
Other Investing Acitivies
n/a n/a n/a 13K
Investing Cash Flow
-123.35M 11.16M 11.06M -39.5M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 24.35M -44K -2K
Financial Cash Flow
69.36M 187.76M 18K 115.94M
Net Cash Flow
-114.07M 131.64M -42.57M 44.35M
Free Cash Flow
-77.98M -75.12M -58.86M -36.54M